Phosphate binder pill burden, adherence, and serum phosphorus control among hemodialysis patients converting to sucroferric oxyhydroxide

BACKGROUND: Phosphate binders are widely used to achieve serum phosphorus control in patients with end-stage renal disease. However, the large pill burden associated with these medications may decrease adherence to therapy. In clinical trials, sucroferric oxyhydroxide (SO) demonstrated equivalent co...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Int J Nephrol Renovasc Dis
Päätekijät: Gray, Kathryn, Ficociello, Linda H, Hunt, Abigail E, Mullon, Claudy, Brunelli, Steven M
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove Medical Press 2019
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6348967/
https://ncbi.nlm.nih.gov/pubmed/30774412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S182747
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia